Publications by authors named "Per B Fischer"

Claim this Profile
S
Safety and immunogenicity of a single booster dose of the group B streptococcus AlpN candidate vaccine (GBS-AlpN) in previously vaccinated healthy women compared with a single dose in previously unvaccinated women.
Bengt Johansson-Lindbom, Geoff Kitson, Lidia Oostvogels, Michael Darsley, Per B Fischer

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a novel Group B Streptococcus (GBS) vaccine candidate for maternal immunization based upon the alpha-like protein family of GBS surface proteins (Alp).
Christopher Banks, Bengt J Lindbom, Geoff Kitson, Michael Darsley, Per B Fischer

Birth Defects Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the group B vaccine AlpN in a placebo-controlled double-blind phase 1 trial.
Majela Gonzalez-Miro, Andrzej Pawlowski, Janne Lehtonen, Duojia Cao, Sara Larsson, Per B Fischer

iScience· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B Streptococcus Infection.
Alyssa Brokaw, Shayla Nguyen, Phoenicia Quach, Austyn Orvis, Anna Furuta, Per B Fischer

J Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A group B alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains.
Andrzej Pawlowski, Jonas Lannergård, Majela Gonzalez-Miro, Duojia Cao, Sara Larsson, Per B Fischer

Cell Rep Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis